Jade Williams, Author at European Medical Journal - Page 13 of 22

Pharma in Kenya

Kenya is home to a budding pharma sector, but the country still faces access to medicine challenges. What are they, and how can pharma help?

First RSV vaccine for older adults earns pivotal Phase 3 results

A first-in-class vaccine for respiratory syncytial virus has shown to be highly efficacious in a Phase III trial, GSK has announced.

Promising outlook for integrating young talent in pharma

Collaboration between the pharmaceutical industry and academia is on the rise, according to a recent survey from the ABPI.

Pfizer-BioNTech assemble with the Avengers in COVID booster drive

Pfizer and BioNTech collaborate with Marvel on a comic encouraging COVID-19 booster vaccinations in the US.

Moderna joins BIA as 500th member

Moderna has joined the UK’s BioIndustry Association (BIA), taking the trade association’s membership to over 500 companies.

Roundtable: a discussion on the pandemic and gender parity

Hear from two industry thought leaders to find out how the pharmaceutical industry is harnessing the COVID-19 to advance rather than derail their mission to improve female representation.

A roundtable on clinical trial transformation

Clinical trials of the past struggled with patient enrolment and cost efficiency. What can the pharmaceutical industry learn to improve them?

Roundtable: the evolving landscape of patient advocacy

In this roundtable, hear from two industry thought leaders who share their ideas on how to build synergy between pharma and patients.

GSK and Microsoft tackle Nepal disease transmission

A new disease surveillance project to curb the spread of known and unknown pathogens, especially mosquito-borne illnesses, has been launched by GSK and Microsoft in Nepal.

The leap from medicine to medical affairs

What is it like to switch from medicine to MA, and are we about to see this spike in the wake of COVID-19?